Equity Profile

LIVN

LivaNova PLC

Health CareHealth Care Equipment$4.5B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

LivaNova PLC is a health care company that specializes in medical devices and therapies for patients with neurological and cardiovascular conditions. With a market cap of $5 billion, it plays a significant role in the health care equipment sector, which is increasingly focused on innovative solutions to improve patient outcomes.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, reflecting how much profit is attributed to each share.

$1.09

Revenue

Total revenue shows the company's ability to generate sales and is crucial for assessing growth and market demand for its products.

$381M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LIVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

In Q1-2026, LivaNova reported an EPS of $0.98, significantly beating expectations of $0.72, which resulted in a 15.05% increase in stock price the following day. The company continues to show strong performance, maintaining a consistent track record of exceeding earnings estimates.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect LivaNova to continue its positive momentum in Q2-2026, with a consensus EPS of $1.09 and revenue of $381 million. The company's history of beating earnings estimates may lead to optimistic sentiment among investors.

Bull Case

If LivaNova can deliver strong earnings and revenue growth, it may reinforce investor confidence and lead to a significant stock price increase, especially given its history of positive surprises.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, particularly given the high implied volatility in the options market.

Key Metrics to Watch

EPS

$1.09

Earnings per share is a key indicator of the company's profitability and financial health, reflecting how much profit is attributed to each share.

Revenue

$381M

Total revenue shows the company's ability to generate sales and is crucial for assessing growth and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will LivaNova's EPS exceed the consensus estimate of $1.09?

A beat on EPS would continue the trend of positive surprises and could boost investor confidence.

What guidance will LivaNova provide regarding future revenue growth?

Future revenue guidance is critical for assessing the company's growth trajectory and could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating LivaNova's ability to sustain its earnings growth, as recent trends suggest stronger demand for its products than reflected in consensus estimates.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a larger move than historical averages, signaling heightened expectations.

The recent positive stock reactions following earnings surprises may indicate a stronger investor sentiment.

Key Risk

If LivaNova's revenue growth comes in below $370 million, it could undermine the bullish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching LivaNova's ability to maintain its earnings momentum and provide positive guidance for future quarters.

Bull Confirmed If

An EPS of $1.12 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.06 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±21.07%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±21.1% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

55.5%

Calls (200)P/C Ratio: 0.67Puts (400)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations and raises guidance, history suggests a positive stock reaction of around +2.92%, confirming the bullish sentiment.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may see a muted reaction as investors digest the commentary.

Miss

A miss on earnings could lead to a decline in stock price, with historical patterns suggesting a drop of around -5.80%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Details on market demand trends for LivaNova's key product lines.
3Management's outlook on competitive pressures in the health care equipment sector.
4Insights into cost management strategies and their effect on margins.
5Any commentary on regulatory developments that could impact operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, reflecting how much profit is attributed to each share.

$1.09

Revenue

Total revenue shows the company's ability to generate sales and is crucial for assessing growth and market demand for its products.

$381M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LIVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If LivaNova can deliver strong earnings and revenue growth, it may reinforce investor confidence and lead to a significant stock price increase, especially given its history of positive surprises.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a sharp decline in stock price, particularly given the high implied volatility in the options market.

Key Metrics to Watch

EPS

$1.09

Earnings per share is a key indicator of the company's profitability and financial health, reflecting how much profit is attributed to each share.

Revenue

$381M

Total revenue shows the company's ability to generate sales and is crucial for assessing growth and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will LivaNova's EPS exceed the consensus estimate of $1.09?

A beat on EPS would continue the trend of positive surprises and could boost investor confidence.

What guidance will LivaNova provide regarding future revenue growth?

Future revenue guidance is critical for assessing the company's growth trajectory and could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating LivaNova's ability to sustain its earnings growth, as recent trends suggest stronger demand for its products than reflected in consensus estimates.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a larger move than historical averages, signaling heightened expectations.

The recent positive stock reactions following earnings surprises may indicate a stronger investor sentiment.

Key Risk

If LivaNova's revenue growth comes in below $370 million, it could undermine the bullish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching LivaNova's ability to maintain its earnings momentum and provide positive guidance for future quarters.

Bull Confirmed If

An EPS of $1.12 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $1.06 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±21.07%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±21.1% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

55.5%

Calls (200)P/C Ratio: 0.67Puts (400)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations and raises guidance, history suggests a positive stock reaction of around +2.92%, confirming the bullish sentiment.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may see a muted reaction as investors digest the commentary.

Miss

A miss on earnings could lead to a decline in stock price, with historical patterns suggesting a drop of around -5.80%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Details on market demand trends for LivaNova's key product lines.
3Management's outlook on competitive pressures in the health care equipment sector.
4Insights into cost management strategies and their effect on margins.
5Any commentary on regulatory developments that could impact operations.